Masters Capital Management LLC Purchases 250,002 Shares of Senseonics Holdings, Inc. Common Stock $SENS

Masters Capital Management LLC boosted its position in shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) by 100.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 500,000 shares of the company’s stock after purchasing an additional 250,002 shares during the quarter. Masters Capital Management LLC’s holdings in Senseonics Holdings, Inc. Common Stock were worth $3,330,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Jain Global LLC purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth $88,000. State of Wyoming increased its stake in shares of Senseonics Holdings, Inc. Common Stock by 202.6% during the second quarter. State of Wyoming now owns 182,989 shares of the company’s stock valued at $87,000 after buying an additional 122,510 shares during the period. Hudson Bay Capital Management LP bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at about $85,000. Beck Mack & Oliver LLC raised its holdings in shares of Senseonics Holdings, Inc. Common Stock by 16.5% in the second quarter. Beck Mack & Oliver LLC now owns 176,950 shares of the company’s stock valued at $84,000 after acquiring an additional 25,000 shares in the last quarter. Finally, Captrust Financial Advisors purchased a new stake in Senseonics Holdings, Inc. Common Stock in the fourth quarter worth about $77,000. 12.36% of the stock is owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Stock Performance

SENS opened at $4.86 on Monday. The company has a current ratio of 3.51, a quick ratio of 3.19 and a debt-to-equity ratio of 1.05. The company has a market cap of $203.15 million, a price-to-earnings ratio of -2.43 and a beta of 0.99. Senseonics Holdings, Inc. Common Stock has a 12 month low of $4.79 and a 12 month high of $11.60. The stock has a fifty day moving average of $6.03.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.71) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. The company had revenue of $11.71 million for the quarter. On average, equities research analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.38 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Mizuho dropped their target price on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Weiss Ratings lowered shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 28th. HC Wainwright lowered their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th. Finally, Stifel Nicolaus dropped their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Monday, May 11th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Senseonics Holdings, Inc. Common Stock has an average rating of “Moderate Buy” and an average price target of $17.20.

Insider Buying and Selling

In other news, Director Douglas A. Roeder purchased 22,686 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was acquired at an average cost of $5.56 per share, with a total value of $126,134.16. Following the completion of the transaction, the director owned 144,635 shares in the company, valued at $804,170.60. This represents a 18.60% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 4.70% of the company’s stock.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.